US20240156739
2024-05-16
Human necessities
A61K9/2095
The production of solid dosage forms, such as tablets, is revolutionized through the use of fused filament fabrication (FFF) 3D printing technology. This innovative approach employs specialized printing filaments that contain active pharmaceutical ingredients, allowing for robust and customizable formulations. The method enables the on-demand creation of personalized medicines tailored to individual patient needs, a significant advancement in the pharmaceutical field.
The solid dosage form printing apparatus consists of several essential components:
Traditional methods of producing solid dosage forms often involve complex processes and large-scale production, which can limit consumer choice and customization. The 3D printing method addresses these challenges by:
The method involves several steps to produce solid dosage forms using the described apparatus. Initially, the printer is set up with the appropriate filaments. The active ingredient-containing filament is printed onto the build platform, followed by any additional filaments as needed. Post-printing modifications can also be performed to enhance the properties of the final product.
This technology has significant implications for healthcare by providing a more efficient means of producing customized medications. It allows pharmacies to print medications on-site, reducing wait times and improving patient adherence to treatment regimens. Furthermore, it opens avenues for research and development in pharmaceutical formulations, enabling rapid prototyping and testing of new drugs.